These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22041830)

  • 1. Renal failure in chronic liver disease and the hepatorenal syndrome.
    Srivastava B; Alexander GJ
    Br J Hosp Med (Lond); 2011 Sep; 72(9):497-503. PubMed ID: 22041830
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
    Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
    Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal impairment in liver diseases].
    Gerbes AL; Gülberg V
    Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
    Mulkay JP; Louis H; Donckier V; Bourgeois N; Adler M; Deviere J; Le Moine O
    Acta Gastroenterol Belg; 2001; 64(1):15-9. PubMed ID: 11322061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The modern possibilities of the hepato-renal syndrome treatment].
    Blokhina NV; Pasechnik IN
    Khirurgiia (Mosk); 2013; (8):81-5. PubMed ID: 24344429
    [No Abstract]   [Full Text] [Related]  

  • 8. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatorenal syndrome.
    Cárdenas A; Uriz J; Ginès P; Arroyo V
    Liver Transpl; 2000 Jul; 6(4 Suppl 1):S63-71. PubMed ID: 10915194
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R
    J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H; Chawla Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.
    Alessandria C; Venon WD; Marzano A; Barletti C; Fadda M; Rizzetto M
    Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1363-8. PubMed ID: 12468959
    [TBL] [Abstract][Full Text] [Related]  

  • 17.  Hepatorenal syndrome: Current concepts related to diagnosis and management.
    de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
    Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
    Dagher L; Patch D; Marley R; Moore K; Burroughs A
    Aliment Pharmacol Ther; 2000 May; 14(5):515-21. PubMed ID: 10792112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
    Salerno F; Gerbes A; Ginès P; Wong F; Arroyo V
    Gut; 2007 Sep; 56(9):1310-8. PubMed ID: 17389705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.